ω-3 Fatty Acids in the Prevention of Cognitive Decline in Humans

被引:130
作者
Cederholm, Tommy [1 ,2 ]
Salem, Norman, Jr. [3 ]
Palmblad, Jan [4 ]
机构
[1] Uppsala Univ, Uppsala, Sweden
[2] Univ Uppsala Hosp, Dept Geriatr Med, Uppsala, Sweden
[3] DSM Nutr Prod, Columbia, MD USA
[4] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Stockholm, Sweden
基金
美国国家卫生研究院;
关键词
FATTY-ACID-COMPOSITION; MATTER WHITE-MATTER; DOCOSAHEXAENOIC ACID; ALZHEIMER-DISEASE; DOUBLE-BLIND; FISH-OIL; LIPID-COMPOSITION; BRAIN; SUPPLEMENTATION; DEMENTIA;
D O I
10.3945/an.113.004556
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 [营养与食品卫生学];
摘要
The brain is a lipid-rich organ where docosahexaenoic acid (DHA) is enriched and where eicosapentaenoic acid (EPA) may have anti-inflammatory effects. The potential role for n-3 (omega-3) fatty acids such as DHA and EPA in the prevention of cognitive decline, including Alzheimer's disease (AD) has attracted major interest for the past 20 y. This review presents our understanding of recent observational, interventional, and experimental studies, with the aim of providing some answers to the following question: Can n-3 FA intake modulate cognitive function during aging? In longitudinal observation studies we mainly observe inverse relations between fish intake or serum concentrations of DHA and cognitive impairment. Intervention studies of EPA and DHA supplementation in healthy old individuals have been negative so far (i.e., after up to 2 years of treatment, no differences in cognitive decline between treated and nontreated participants have been observed). In studies that provided EPA and DHA to adults with mild cognitive impairment or age-related cognitive impairment the data seem to be positive. However, when patients with established AD were supplemented with EPA and DHA it appears no benefit was gained. For studies on healthy individuals, a major concern is that the treatment periods may have been too short. There might also be subgroup effects because of the Carriage of apolipoprotein E epsilon 4 alleles or risk factor burden. Experimental studies appear to be consistently positive (i.e., n-3 FA supplementation in rodents over a substantial portion of their lives reduces amyloid-beta deposition and hippocampal neuron loss and improves cognitive functioning). We are getting closer to providing evidence-based recommendations on fish and fish oil intake to facilitate memory function during old age. In the meantime it is advised to follow the general CDC dietary recommendations of 2-3 fish meals per week or the equivalent intake of long chain n-3 fatty acids, particularly DHA.
引用
收藏
页码:672 / 676
页数:5
相关论文
共 40 条
[1]
Docosahexaenoic acid: A positive modulator of Akt signaling in neuronal survival [J].
Akbar, M ;
Calderon, F ;
Wen, ZM ;
Kim, HY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (31) :10858-10863
[2]
Fish, meat, and risk of dementia:: cohort study [J].
Barberger-Gateau, P ;
Letenneur, L ;
Deschamps, V ;
Pérès, K ;
Dartigues, JF ;
Renaud, S .
BRITISH MEDICAL JOURNAL, 2002, 325 (7370) :932-+
[3]
BRECKENRIDGE WC, 1972, BIOCHIM BIOPHYS ACTA, V266, P695, DOI 10.1016/0006-3002(72)90012-1
[4]
Docosahexaenoic acid promotes neurite growth in hippocampal neurons [J].
Calderon, F ;
Kim, HY .
JOURNAL OF NEUROCHEMISTRY, 2004, 90 (04) :979-988
[5]
The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects [J].
Carver, JD ;
Benford, VJ ;
Han, B ;
Cantor, AB .
BRAIN RESEARCH BULLETIN, 2001, 56 (02) :79-85
[6]
Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia? [J].
Cederholm, Tommy ;
Palmblad, Jan .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2010, 13 (02) :150-155
[7]
The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study [J].
Chiu, Chih-Chiang ;
Su, Kuan-Pin ;
Cheng, Tsung-Chi ;
Liu, Hsing-Cheng ;
Chang, Ching-Jui ;
Dewey, Michael E. ;
Stewart, Robert ;
Huang, Shih-Yi .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (06) :1538-1544
[8]
Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial [J].
Dangour, Alan D. ;
Allen, Elizabeth ;
Elbourne, Diana ;
Fasey, Nicky ;
Fletcher, Astrid E. ;
Hardy, Pollyanna ;
Holder, Graham E. ;
Knight, Rosemary ;
Letley, Louise ;
Richards, Marcus ;
Uauy, Ricardo .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2010, 91 (06) :1725-1732
[9]
National Institutes of Health State-of-the-Science Conference Statement: Preventing Alzheimer Disease and Cognitive Decline [J].
Daviglus, Martha L. ;
Bell, Carl C. ;
Berrettini, Wade ;
Bowen, Phyllis E. ;
Connolly, E. Sander, Jr. ;
Cox, Nancy Jean ;
Dunbar-Jacob, Jacqueline M. ;
Granieri, Evelyn C. ;
Hunt, Gail ;
McGarry, Kathleen ;
Patel, Dinesh ;
Potosky, Arnold L. ;
Sanders-Bush, Elaine ;
Silberberg, Donald ;
Trevisan, Maurizio .
ANNALS OF INTERNAL MEDICINE, 2010, 153 (03) :176-U72
[10]
Polyunsaturated docosahexaenoic vs docosapentaenoic acid - Differences in lipid matrix properties from the loss of one double bond [J].
Eldho, NV ;
Feller, SE ;
Tristram-Nagle, S ;
Polozov, IV ;
Gawrisch, K .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (21) :6409-6421